General Manager, New Ventures
Mon, Feb 14, 2022
Feb 14
exercised or converted securities in EXAS
2,030 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +20.00% (+1,090 shares)
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services